LYELL IMMUNOPHARMA, INC.

Insiders Lyell Immunopharma, Inc.

Equities

LYEL

US55083R1041

Real-time Estimate Cboe BZX Other stock markets 11:31:06 2024-06-05 am EDT			5-day change	1st Jan Change
2.545 ^USD	+2.21%		+0.20%	+32.22%

May. 06	Sector Update: Health Care Stocks Higher in Late Afternoon Trading	MT
May. 06	Lyell Immunopharma Shares Rise After Q1 Net Loss Narrows	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Insider Sell: Lyell Immunopharma	23-08-17	MT
Lyell Immunopharma Names Chief Business Officer	23-07-05	MT
Lyell Immunopharma, Inc. Appoints Matthew Lang as Chief Business Officer	23-07-05	CI
Lyell Immunopharma, Inc. Announce Resignation of Rahsaan Thompson as the Chief Legal Officer	23-06-06	CI
Lyell Immunopharma Names Lynn Seely as Chief Executive	22-12-15	MT
Lyell Immunopharma, Inc. Appoints Lynn Seely as CEO	22-12-15	CI
Lyell Immunopharma, Inc. Appoints Lynn Seely as President	22-12-15	CI
Lyell Immunopharma Names Rahsaan W. Thompson Chief Legal Officer	22-09-28	MT
Lyell Immunopharma, Inc. Announces the Appointment of Rahsaan W. Thompson as Chief Legal Officer	22-09-28	CI
Lyell Immunopharma Names Gary Lee as Chief Scientific Officer	22-02-01	MT
Lyell Immunopharma Announces Executive Changes	22-01-31	CI
Lyell Immunopharma, Inc. Announces Richard Klausner Return from His Medical Leave to Continue as Chair of the Board	21-12-03	CI
Lyell Immunopharma Chairman Rick Klausner Emerges From Medical Leave	21-12-03	MT
Lyell Immunopharma, Inc. Announces Promotion of Stephen Hill to Chief Operating Officer	21-10-28	CI
Lyell Immunopharma, Inc. Announces Executive Changes	21-09-30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer